(Q40379845)

20 September 2017

title

Recommendations on therapy using interleukin-1beta-blocking agents (English)

1 reference

20 September 2017

B Manger

1

1 reference

20 September 2017

M Gaubitz

2

1 reference

20 September 2017

H Michels

3

1 reference

20 September 2017

Kommission Pharmakotherapie der DGRh

4

1 reference

20 September 2017

German Society of Rheumatology

5

1 reference

20 September 2017

language of work or name

German

0 references

publication date

1 November 2009

1 reference

20 September 2017

number of pages

6

1 reference

Zeitschrift fuer Rheumatologie

inferred from page(s)

published in

1 reference

20 September 2017

volume

68

1 reference

20 September 2017

issue

9

1 reference

20 September 2017

page(s)

766-771

1 reference

Treatment of familial Mediterranean fever with anakinra.

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00393-009-0542-3

Resistant Behçet disease responsive to anakinra

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00393-009-0542-3

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

12 December 2020

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever

1 reference

12 December 2020

Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report

1 reference

12 December 2020

[Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra]

1 reference

12 December 2020

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis

1 reference

12 December 2020

Refractory adult onset Still's disease successfully treated with anakinra

1 reference

12 December 2020

Efficacy of anakinra in a patient with refractory relapsing polychondritis

1 reference

12 December 2020

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome

1 reference

12 December 2020

Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra.

1 reference

12 December 2020

Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome

1 reference

12 December 2020

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

1 reference

12 December 2020

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

1 reference

12 December 2020

[Interdisciplinary and evidence-based treatment guideline for juvenile idiopathic arthritis]

1 reference

12 December 2020

Schnitzler's syndrome--exacerbation after anti-TNF treatment

1 reference

12 December 2020

Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra

1 reference

12 December 2020

Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome

1 reference

12 December 2020

[Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)]

1 reference

12 December 2020

Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.

1 reference

12 December 2020

Colchicine for familial Mediterranean fever

1 reference

12 December 2020

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

1 reference

12 December 2020

Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA)

1 reference

12 December 2020

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

1 reference

12 December 2020

IL-1RA in refractory systemic lupus erythematosus

1 reference

12 December 2020

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

12 December 2020

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

1 reference

12 December 2020

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

1 reference

12 December 2020

Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease

1 reference

12 December 2020

Anakinra for rheumatoid arthritis: a systematic review

1 reference

12 December 2020

Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.

1 reference

12 December 2020

Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra

1 reference

12 December 2020

Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity

1 reference

12 December 2020

Adult onset Still's disease

1 reference

12 December 2020

Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)

1 reference

12 December 2020

Schnitzler syndrome: treatment failure to rituximab but response to anakinra

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

12 December 2020

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

1 reference

12 December 2020

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

1 reference

12 December 2020

Prompt response of refractory Schnitzler syndrome to treatment with anakinra.

1 reference

12 December 2020

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

1 reference

12 December 2020

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

12 December 2020

Successful treatment of resistant pseudogout with anakinra

1 reference

12 December 2020

Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra

1 reference

12 December 2020

Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra.

1 reference

12 December 2020

Colchicine: 1998 update.

1 reference

12 December 2020

Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis

1 reference

12 December 2020

Successful use of anakinra to treat refractory Schnitzler's syndrome.

1 reference

12 December 2020

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome

1 reference

12 December 2020

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

12 December 2020

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

1 reference

12 December 2020

A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients

1 reference

12 December 2020

Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment

1 reference

12 December 2020

Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism

1 reference

12 December 2020

The systemic autoinflammatory diseases: inborn errors of the innate immune system.

1 reference

12 December 2020

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.

1 reference

12 December 2020

A pilot study of IL-1 inhibition by anakinra in acute gout

1 reference

12 December 2020

Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study

1 reference

12 December 2020

Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.

1 reference

12 December 2020

Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome

1 reference

12 December 2020

Diagnosis and management of adult onset Still's disease

1 reference

12 December 2020

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations

1 reference

12 December 2020

10.1007/S00393-009-0542-3

Identifiers

DOI

1 reference

20 September 2017

1 reference